261, 262 Although high rates of efficacy were reported (47 to 64%), given the extremely small combined sample size of fewer than 30 patients, the relatively serious AEs (e.g., new diabetes onset, exacerbation of existing diabetes, pneumonia with septic shock, increased blood pressure), and the known risks of systemic long-term glucorticoid use, risks/burdens clearly outweigh benefits and the Panel recommends that this therapy not be used long-term
Most commercial plans classify weight-loss GLP-1s as external-issue specialty drugs , often requiring initial dispensing through limited network pharmacy hubs
No matter how obvious the signs seem to you based on so much information we have provided and is available across the web, but seeking help from a doctor is the best way to avoid unnecessary health hazards that may come your way if you try and test with your menstrual cycle
Both Mounjaro and Zepbound are effective for managing type 2 diabetes and promoting weight loss, although Zepbound is specifically approved for weight management
If you need long-term acid reduction, then the PPI is more effective